Combination activity of eribulin liposomal formulation and anti-PD-1 antibody after tumor regrowth during anti-PD-1 antibody treatment in mice

被引：0
|
作者：
Tamura, Moe
Niwa, Yuki
Semba, Taro
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-5260
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5260
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Re: Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
    Daskivich, Timothy J.
    Belldegrun, Arie
    EUROPEAN UROLOGY, 2015, 67 (04) : 816 - 817
  • [32] Anti-PD-1 Antibody Treatment Promotes Clearance of Persistent Cryptococcal Lung Infection in Mice
    Roussey, Jonathan A.
    Viglianti, Steven P.
    Teitz-Tennenbaum, Seagal
    Olszewski, Michal A.
    Osterholzer, John J.
    JOURNAL OF IMMUNOLOGY, 2017, 199 (10): : 3535 - 3546
  • [33] Successful treatment of refractory Sezary syndrome by anti-PD-1 antibody (nivolumab)
    Kaini Shen
    Yuehua Liu
    Xinxin Cao
    Daobin Zhou
    Jian Li
    Annals of Hematology, 2017, 96 : 687 - 688
  • [34] Anti-PD-1 antibody scFv producing recombinant Bifidobacterium exerts antitumor effect in a larger fraction of the treated mice compared to full-length anti-PD-1 antibody
    Shioya, Koichiro
    Wang, Li
    Matsumura, Tomio
    Shimizu, Hitomi
    Kanari, Yasuyoshi
    Seki, Yuji
    Shimatani, Yuko
    Taniguchi, Shun'ichiro
    Kataoka, Shiro
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (09)
  • [35] Tusamitamab ravtansine induces immunogenic cell death and synergizes with anti-PD-1 or anti-PD-L1 antibody combination in solid tumor
    Nicolazzi, Celine
    Lefebvre, Anne-Marie
    Moindrot, Nicolas
    Larois, Christelle
    Classe, Marion
    Sidhu, Sukhvinder
    CANCER RESEARCH, 2024, 84 (06)
  • [36] Dostarlimab Anti-PD-1 monoclonal antibody Treatment of advanced solid tumors
    Haddley, K.
    DRUGS OF THE FUTURE, 2019, 44 (07) : 527 - 534
  • [37] Successful treatment of refractory Sezary syndrome by anti-PD-1 antibody (nivolumab)
    Shen, Kaini
    Liu, Yuehua
    Cao, Xinxin
    Zhou, Daobin
    Li, Jian
    ANNALS OF HEMATOLOGY, 2017, 96 (04) : 687 - 688
  • [38] Evaluation of the antitumor activity of moronecidin (Piscidin) like peptide in combination with anti-PD-1 antibody against melanoma tumor
    Mohammadi, Mohsen
    Hasan-Abad, Amin Moradi
    Ghasemi, Ali
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2023, 26 (09) : 1061 - 1067
  • [39] A Case of Acute Myocarditis During Treatment With Anti-PD-1 Antibody Nivolumab in a Melanoma Patient
    Tadokoro, Tomonori
    Keshino, Eri
    Mohri, Masahiro
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (09) : S220 - S220
  • [40] Vibostolimab, an anti-TIGIT antibody, as monotherapy and in combination with pembrolizumab in anti-PD-1/PD-L1-refractory NSCLC
    Ahn, M-J.
    Niu, J.
    Kim, D-W.
    Rasco, D.
    Mileham, K. F.
    Chung, H. C.
    Vaishampayan, U. N.
    Maurice-Dror, C.
    Lo Russo, P.
    Golan, T.
    Chartash, E.
    Chen, D.
    Healy, J.
    Rajasagi, M.
    Lee, D. H.
    ANNALS OF ONCOLOGY, 2020, 31 : S887 - S887
12345